Explore
Validate
Learn17868-1-AP
antibody from Proteintech Group
Targeting: CYP2D6
CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, P450-DB1, P450C2D
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 17868-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- CYP2D6/7 antibody
- Antibody type
- Polyclonal
- Description
- CYP2D6/7 antibody (Cat. #17868-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Cloning, sequence analysis, and tissue expression of marmoset paraoxonase 1.
Effects of Saikosaponin D on CYP1A2 and CYP2D6 in HepaRG Cells.
Silybin enhances the blood concentration of brexpiprazole in rats by downregulating expression of CYP3A4 and CYP2D6.
Generation of hepatic spheroids using human hepatocyte-derived liver progenitor-like cells for hepatotoxicity screening.
CYP enzymes, expressed within live human suspension cells, are superior to widely-used microsomal enzymes in identifying potent CYP1A1/CYP1B1 inhibitors: Identification of quinazolinones as CYP1A1/CYP1B1 inhibitors that efficiently reverse B[a]P toxicity and cisplatin resistance.
Uehara S, Uno Y, Shimizu M, Yamazaki H
Drug metabolism and pharmacokinetics 2021 Aug;39:100398
Drug metabolism and pharmacokinetics 2021 Aug;39:100398
Effects of Saikosaponin D on CYP1A2 and CYP2D6 in HepaRG Cells.
Li H, Tang Y, Wang Y, Wei W, Yin C, Tang F
Drug design, development and therapy 2020;14:5251-5258
Drug design, development and therapy 2020;14:5251-5258
Silybin enhances the blood concentration of brexpiprazole in rats by downregulating expression of CYP3A4 and CYP2D6.
Yu C, Pan L, Wang G, Cai Z, Zhou Y, Zheng X, Chen C, Zhang X
Die Pharmazie 2020 May 1;75(5):198-200
Die Pharmazie 2020 May 1;75(5):198-200
Generation of hepatic spheroids using human hepatocyte-derived liver progenitor-like cells for hepatotoxicity screening.
Wang Z, Li W, Jing H, Ding M, Fu G, Yuan T, Huang W, Dai M, Tang D, Zeng M, Chen Y, Zhang H, Zhu X, Peng Y, Li Q, Yu WF, Yan HX, Zhai B
Theranostics 2019;9(22):6690-6705
Theranostics 2019;9(22):6690-6705
CYP enzymes, expressed within live human suspension cells, are superior to widely-used microsomal enzymes in identifying potent CYP1A1/CYP1B1 inhibitors: Identification of quinazolinones as CYP1A1/CYP1B1 inhibitors that efficiently reverse B[a]P toxicity and cisplatin resistance.
Sonawane VR, Siddique MUM, Gatchie L, Williams IS, Bharate SB, Jayaprakash V, Sinha BN, Chaudhuri B
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2019 Apr 1;131:177-194
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2019 Apr 1;131:177-194
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- mouse liver tissue were subjected to SDS PAGE followed by western blot with 17868-1-AP( CYP2D6 Antibody) at dilution of 1:300
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The CYP2D6 antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human CYP2D6. This antibody recognizes human,mouse,rat antigen. The CYP2D6 antibody has been validated for the following applications: ELISA, IHC, WB analysis.
